Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > To Peladawn

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jun 22, 2024 4:15pm

62 Views

Post# 36101791

RE:RE:RE:RE:To Peladawn

Pelaboost....just for laughs, maybe you could try to honestly answer a serious question:

How would you react, and how would the mainstream media react, if it was found out that Eric Trump had 20 shell companies and was getting money from countries like Ukraine, Russia, and China, while his father was president?.......I challenge you to give me a thoughtful and truthful answer.....then you can ask me one about my "opinion", as you put it

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Cannabis Report – Nov. 22, 2024